Austin Westerling is a seasoned finance professional currently serving as a Partner at Granite Point Capital, where responsibilities include managing long/short public hedge and venture capital funds since November 2012. Westerling is also actively involved in various investment roles, including Series B investor at Route, Series C investor at Divvy, and Series A investor at multiple companies such as Receptor Life Sciences, Acreage Holdings, Cerebral Therapeutics, Tevard Biosciences, and Tilray. Additionally, Westerling holds a board membership at Teikametrics. An alumnus of Yale University, Westerling graduated with a BA in Economics and Psychology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices